Aims & Scope & Index
The Eurasian Clinical and Analytical Medicine (ECAM) is an international peer-reviewed English-language journal containing peer-reviewed high-quality articles on clinical medicine. The Journal welcomes submissions in English of all research study types, reviews, and case reports. It provides comprehensive and unique information with a worldwide readership. The journal is published three times a year (in January, May and September). The authors undertake all scientific responsibility for their manuscripts. All the printed and digital content of this journal is archived in the Internet Archive.
Journal title abbreviation: Eu Clin Anal Med
Publisher: Bayrakol Medical Publishing
Index: Google Scholar, Türkiye Atıf Dizini
Archive: Internet Archive
Online ISSN: 2667-6451
In 2020, 5 articles published in ECAM including original researchs and reviews.
Open Access Policy
The Journal is an open- access journal; individuals can freely access, read, save, copy, scan, link the entire text, index, transfer the published content into a software and use the published content for all legal purposes. The content of the journal is open to access in line with the policy of Budapest Open Access Initiative for developing, supporting, and extending the science. If the purpose is scientific citations, other than commercial purposes, the content of the journal can be used by the license of the Creative Commons Attribution-NonCommercial 4.0 International Licence (CC BY-NC). For commercial use by individuals, it is necessary to obtain written permission from the journal. The journal has not article processing charges (APCs) and/or submission charges. The content of the Eurasian Clinical and Analytical Medicine is licensed under Creative Commons Attribution-NonCommercial 4.0 International Licence.
Eurasian Clinical and Analytical Medicine does NOT charge a fee for submission, processing or publication from authors.
NO PUBLICATION FEE!
NO SUBMISSION FEE!
Peer Review Process
When the submitted articles arrived to the journal, one of the Editors read each manuscript. Editors have to make first decision very quickly. We aim to make the first decision on all manuscripts within one or two weeks after submission. During the first decision, the journal editors mainly check whether the manuscript is consistent with the scope and objectives of the journal and the minimum acceptable quality, whether the manuscript complies with journal instructions for the authors. The editor decides whether to send it for a full review. If a paper is rejected without external review, authors are notified electronically on decision time by email. We retain copies of rejected manuscripts for three months, after which we delete them from our system.
Only after passing the initial screening, the manuscript is sent for double-blind review. At least two peer-reviewers are selected for the peer-review process. Names of reviewers and authors are not revealed to each other. We encourage reviewers to help authors improve their manuscripts. The report should contain constructive analysis for authors, especially where revision is recommended. If reviewers do not wish authors to see certain comments, these can be added to confidential comments for the editor.
While expectations vary by discipline, some key aspects that should be evaluated by reviewers may include:
Are the research questions valid?
Is the sample size sufficient?
Is there necessary ethical approval and/or consent and was the research ethical?
Are the study design and methods appropriate to answer the research question?
Do the experiments have appropriate controls?
Is the reporting of the methods, including any equipment and materials, sufficiently detailed that the research might be reproduced?
Are statistical tests appropriate and correctly reported?
Are the figures and tables clear and do they accurately represent the results?
Has previous research by the authors and others been discussed and have those results been compared to the current results?
Are there any inappropriate citations, for example, not supporting the claim being made or too many citations to the authors’ own articles?
Do the results support the conclusions?
Are limitations of the research acknowledged?
Is the abstract an accurate summary of the research and results, without spin?
Is the language clear and understandable?
We encourage reviewers to focus their reports on objectively critiquing the scientific aspects of the submission, including soundness of the methodology and whether the conclusions can be supported by the results. Comments may also be given on novelty and the potential impact of the work.
We ask authors to declare potential conflicts of interest any of the reviewers. The final decision concerning the manuscript is made during the regular Editorial meeting. All the evaluation reports from the reviewers are reviewed and the final decision is reached on the base of originality, quality, importance, scientific merit and ethical issues of the article. All authors are asked to submit any conflict of interest, to complete and sign the Copyright Release Form. We send reviewers’ comments to authors, regardless of whether we accept the article or not.
Eurasian Clinical and Analytical Medicine and Bayrakol Medical Publisher expect the highest ethical standards from their authors, reviewers and editors when conducting research, submitting papers and throughout the peer-review process. The Editorial Board of Eurasian Clinical and Analytical Medicine and the Publisher adheres to the principles of the International Committee of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the US National Library of Medicine (NLM), the World Medical Association (WMA), the US Office of Research Integrity (ORI), the European Association of Science Editors (EASE), and the International Society of Managing and Technical Editors (ISMTE). ECAM follows the COPE’s guidance https://publicationethics.org/guidance/Guidelines and complies with its main practices.
Human and Animal Rights
Informed consent must be obtained from each of the research participants. In such studies, the authors must specify that they comply with the international guidelines, the “Regulations on Pharmaceutical Research” enforced by The Ministry of Health of Turkey published in the 27089 numbered Official Journal dated 23 December 2008, and the other regulations published later and all procedures performed in studies involving human participants should be in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. It should be expressed that in the experimental studies that all animals are subject to the ethical treatment in accordance with Guide for the Care and Use of Laboratory Animals. Editors expect that all investigations involving humans are performed in accordance with these principles. For animal experimentation reported in the journal, it is expected that investigators observe the Interdisciplinary Principles and Guidelines for the Use of Animals in Research, Testing, and Education issued by the New York Academy of Sciences’ Adhoc Committee on Animal Research. Studies on animals require ethical approval.
Authors are required to declare the support they received to carry out their research. Declaring funding sources acknowledges funders’ contributions, fulfills funding requirements, and promotes greater transparency in the research process. Information includes the name of granting agencies, grant numbers, and a description of each funder’s role. If the grant is not related to the published research authors are not required to provide the complete list of every single grant that supports them. If the funder has played no role in the research, this must be stated as well. Funding information is entered in the online submission system.
Conflict of Interest Statement
To ensure transparency, all authors, reviewers and editors are required to declare any interests that could compromise, conflict or influence the validity of the publication. Competing interests guidelines can be viewed here. Declared conflicts of interest will be considered by the editor and reviewers and included in the published article. If there is no conflict of interests, the authors should state “The author(s) declare(s) that there are no conflicts of interest regarding the publication of this paper.”
The copyright of published manuscripts is held by the Eurasian Clinical and Analytical Medicine. Any commercial use of data, tables, figures, or videos published in ECAM without the written permission of the publisher is prohibited, even if they are taken from the authors’ own manuscripts to be used in any commercial purpose. This statement is consistent with the Creative Commons (Attribution-Noncommercial) code (http://creativecommons.org/licenses/by-nc/4.0/). The corresponding author must submit Copyright Transfer Form signed by all authors in Online Submission Step to the journal.
Manuscript writers are not paid by any means for their manuscripts. Content of the articles is entirely on the responsibility of the author. For any commercial use of material from this open-access journal, permission must be obtained from Eurasian Clinical and Analytical Medicine.
a. Authors must certify that their manuscripts are their original work.
b. Authors must certify that the manuscript has not previously been published elsewhere.
c. Authors must certify that the manuscript is not currently being considered for publication elsewhere.
d. Authors are expected to be aware of, and comply with, best practice in publication ethics specifically with regard to authorship, dual submission, plagiarism, manipulation of figures, competing interests and compliance with policies on research ethics.
e. Authors are obliged to provide retractions or corrections of mistakes.
f. All authors mentioned in the paper must have significantly contributed to the research. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. The corresponding author should ensure that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.
After the initial submission of a manuscript, any changes whatsoever in authorship (adding author(s), deleting author(s), or re-arranging the order of authors) must be explained by a letter to the editor from the authors concerned. This letter must be signed by all authors of the paper. Copyright assignment must also be completed by every author.
Correction of authorship: ECAM does not correct authorship after publication unless a mistake has been made by the editorial staff. Authorship may be changed before publication but after submission when an authorship correction is requested by all of the authors involved with the manuscript.
Eurasian Clinical and Analytical Medicine evaluates submissions on the understanding that they are the original work of the author(s). Re-use of text, data, figures, or images without appropriate acknowledgment or permission is considered plagiarism, as is the paraphrasing of text, concepts, and ideas. Submitted manuscripts are screened for possible plagiarism/self plagiarism or duplicate publication by the software ( iThenticate: Plagiarism Detection Software (CrossCheck)) and in accordance with COPE guidelines upon arrival. https://publicationethics.org/files/u7140/plagiarism%20A.pdf A letter of permission is required for any and all material that has been published previously. It is the responsibility of the author to request permission from the publisher for any material that is being reproduced. This requirement applies to text, figures, and tables.
Archiving and Data Repository Policy
All the printed and digital content of this journal is archived in the Internet Archive (available from: https://archive.org/details/@eurasian_clinical_and_analytical_medicine) and Google One drive.
Eurasian Clinical and Analytical Medicine allows authors to deposit any version (the Final Published PDF or Accepted Manuscript or Original Submission) of their manuscript in institutional or other repositories as long as its original authors, citation details, and publisher are identified. Written permission from the publisher is required for commercial use of the content.